Chronic Migraine, Headache Clinical Trials

12 recruitingLast updated: June 18, 2026

There are 12 actively recruiting chronic migraine, headache clinical trials across 18 countries. Studies span Not Applicable, Early Phase 1, Phase 3. Top locations include Barcelona, Barcelona, Spain, Albacete, Spain, Badalona, Barcelona, Spain. Updated daily from ClinicalTrials.gov.


Chronic Migraine, Headache Trials at a Glance

12 actively recruiting trials for chronic migraine, headache are listed on ClinicalTrialsFinder across 6 cities in 18 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Barcelona, Albacete, and Badalona. Lead sponsors running chronic migraine, headache studies include Hospital Universitari Vall d'Hebron Research Institute, Istituto per la Ricerca e l'Innovazione Biomedica, and Beijing Tiantan Hospital.

Browse chronic migraine, headache trials by phase

Treatments under study

About Chronic Migraine, Headache Clinical Trials

Looking for clinical trials for Chronic Migraine, Headache? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Chronic Migraine, Headache trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Chronic Migraine, Headache clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Not Applicable

Ultrasound Guided Infratemporal Sphenopalatine Ganglion Supravoltage Versus Standard Voltage Pulsed Radiofrequency for Pain Alleviation in Chronic Refractory Migraine.

Chronic Migraine, Headache
Minia University100 enrolled2 locationsNCT07500558
Recruiting

The Neuroanatomical and Psychological Correlates of Suggestibility in Patients With Non-Responsive Chronic Migraine

Chronic Migraine, Headache
Istituto per la Ricerca e l'Innovazione Biomedica200 enrolled1 locationNCT07617441
Recruiting
Not Applicable

New Methods for Evaluating Preventive Migraine Treatment

MigraineHeadache DisordersChronic Migraine, Headache+1 more
University of Aarhus60 enrolled2 locationsNCT07071506
Recruiting
Not Applicable

Bilateral Embolization of the Middle Meningeal Arteries for Refractory Chronic Migraine

MigraineChronic Migraine, HeadacheRefractory Migraine
Johns Hopkins University13 enrolled1 locationNCT07223008
Recruiting
Not Applicable

Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Migraine

myofascial trigger pointsChronic Migraine, HeadacheGreater Occipital Nerve Block
Beijing Tiantan Hospital1,036 enrolled1 locationNCT07347067
Recruiting

Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine

MigraineEpisodic MigraineChronic Migraine, Headache
Hospital Universitari Vall d'Hebron Research Institute700 enrolled26 locationsNCT07159750
Recruiting
Phase 3

The Nordic Chronic Migraine Trial of CGRP Monoclonal Antibody and Onabotulinumtoxin A Dual Therapy Compared to CGRP mAbs Monotherapy

MigraineChronic Migraine, Headache
Oslo University Hospital450 enrolled6 locationsNCT07040813
Recruiting
Early Phase 1

Study of the Effectiveness and Safety of Embolization of the Middle Meningeal Artery Using Non-adhesive Materials SQUID 12 and SQUID 18 in the Treatment of Patients With Chronic Resistant Migraine

Chronic Migraine, Headache
Vedanta University Clinic30 enrolled1 locationNCT06848166
Recruiting

Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification

migraine headacheMigraine with auraMigraine+5 more
Hospital Universitari Vall d'Hebron Research Institute440 enrolled1 locationNCT06674772
Recruiting
Not Applicable

Efficacy of Nerve Block Versus Botox in Chronic Migraine Management

Chronic MigraineChronic Migraine, Headache
Zagazig University64 enrolled1 locationNCT06684249
Recruiting
Not Applicable

Relieving Chronic Pain: Psychosomatic Mechanisms and Psychological Interventions in Fibromyalgia and Chronic Headache

Fibromyalgia (FM)Chronic Migraine, Headache
University of Roma La Sapienza400 enrolled2 locationsNCT06652724
Recruiting
Not Applicable

Study Using the ShiraTronics Migraine Therapy System

Chronic Migraine, Headache
ShiraTronics40 enrolled4 locationsNCT05700318